Skip to main content
Premium Trial:

Request an Annual Quote

IMIDomics, Celgene Partner on Immune-Mediated Inflammatory Disease Research

NEW YORK (GenomeWeb) — IMIDomics announced today that it has partnered with Celgene to advance Celgene's development of new treatments for immune-mediated inflammatory diseases.

IMIDomics is developing a database of genomic markers derived from biological samples for immune-mediated inflammatory diseases in order to identify factors involved in specific phenotypes, drug response, disease activity, disease severity, and disease stratification. The company focuses on rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, and systemic lupus erythematosus.

Under the terms of their deal, IMIDomics will provide Celgene with access to its clinical and molecular database to identify new targets and biomarkers, support the development of new therapeutic candidates and next-generation companion diagnostics, and enable patient population stratification for clinical trials. Im exchange, IMIDomics will receive undisclosed project funding and stands to receive royalties based on products resulting from the alliance.

Additional terms were not disclosed.

"Under this agreement, we will apply our unique database of clinical, phenotypic, genotypic, and analytical findings to potentially advance and accelerate Celgene's discovery and development efforts targeting diverse immune-mediated inflammatory diseases with substantial unmet needs," IMIDomics Executive Chairman Sandy Zweifach said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.